Development of novel polymer-stabilized diosmin nanosuspensions: In vitro appraisal and ex vivo permeation

International Journal of Pharmaceutics

Volumn 454, Issue 1, 2013, Pages 462-471

  Freag, May S ^a   Elnaggar, Yosra S R ^a   Abdallah, Ossama Y ^a  

^a Alexandria University Faculty of Pharmacy   (Egypt)

Author keywords

Diosmin; Dissolution; Nanocrystals; Nanosuspension; Permeation

Indexed keywords

DIOSMIN; HYDROXYPROPYLMETHYLCELLULOSE; POLYMER;

ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG SOLUBILITY; INFRARED SPECTROSCOPY; PARTICLE SIZE; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SPRAY DRYING; TRANSMISSION ELECTRON MICROSCOPY; X RAY POWDER DIFFRACTION;

EID: 84884160175     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2013.06.039     Document Type: Article

References (55)

1. Balimane, P.V., Chong, S., Morrison, R.A., 2000. Current methodologies used for evaluation of intestinal permeability and absorption. J. Pharmacol. Toxicol. Methods 44, 301-312. (Pubitemid 32239482)
2. Barthe, L., Bessouet, M., Woodley, J.F., Houin, G., 1998. The improved everted gut sac: a simple method to study intestinal P-glycoprotein. Int. J. Pharm. 173, 255-258.
3. Bothiraja, C., Pawar, A.P., Dama, G.Y., Joshi, P.P., Shaikh, K.S., 2012. Novel solvent free gelucire extract of Plumbago zeylanica using non-everted rat intestinal sac method for improved therapeutic efficacy of plumbagin. J. Pharmacol. Toxicol. Methods 66, 35-42.
4. Chang, S.A., Gray, D.G., 1978. The surface tension of aqueous hydroxypropyl cellulose solutions. J. Colloid Interface Sci. 67, 255-265.
5. Chaubal, M.V., Popescu, C., 2008. Conversion of nanosuspensions into dry powders by spray drying: a case study. Pharm. Res. 2510, 2302-2308.
6. Chen, H., Khemtong, C., Yang, X., Chang, X., Gao, J., 2011. Nanonization strategies for poorly water-soluble drugs. Drug Discov. Today 16, 354-360.
7. Chen, H., Wan, J., Wang, Y., Mou, D., Liu, H., Xu, H., Yang, X., 2008. A facile nanoaggregation strategy for oral delivery of hydrophobic drugs by utilizing acid-base neutralization reactions. Nanotechnology 19, 375104-375111.
8. Chen, J.F., Zhou, M.Y., Shao, L., Wang, Y.Y., Yun, J., Chew, N.Y.K., Chan, H.K., 2004. Feasibility of preparing nanodrugs by high-gravity reactive precipitation. Int. J. Pharm. 269, 267-274. (Pubitemid 38032839)
9. Choi, J.-Y., 2005. Role of polymeric stabilizers for drug nanocrystal dispersions. Curr. Appl. Phys. 5, 472-474. (Pubitemid 40714976)
10. Christensen, K.L., Pedersen, G.P., Kristensen, H.G., 2000. Preparation of redispersible dry emulsions by spray drying. Int. J. Pharm. 212, 187-194. (Pubitemid 32119444)
11. Dixit, P.D., Jain, K., Dumbwani, J., 2012. Standardization of an ex vivo method for determination of intestinal permeability of drugs using everted rat intestine apparatus. J. Pharmacol. Toxicol. Methods 65, 13-17.
12. Donga, Y., Nga, W.K., Shena, S., Kima, S., Tana, R.B.H., 2009. Preparation and characterization of spironolactone nanoparticles by antisolvent precipitation. Int J. Pharm. 375, 84-88.
13. Dung, T.D., Day, C.H., Binh, T.V., Lin, C.H., Lin, X., Su, C., Lin, Y., Tsai, F., Kuo, W., Li, X., Kuo, C., 2012. PP2A mediates diosmin p53 activation to block HA22T cell proliferation and tumor growth in xenografted nude mice through PI3K-Akt-MDM2 signaling suppression. Food. Chem. Toxicol. 50, 1802-1810.
14. Eerdenbrugh, B.V., Froyen, L., Martens, J.A., Blaton, N., Augustijns, P., Brewster, M., Mooter, G.V., 2007. Characterization of physico-chemical properties and pharmaceutical performance of sucrose co-freeze-dried solid nanoparticulate powders of the anti-HIV agent loviride prepared by media milling. Int. J. Pharm. 338, 198-206. (Pubitemid 46779149)
15. El-Shafae, A.M., El-Domiaty, M.M., 2001. Improved LC methods for the determination of diosmin and/or hesperidin in plant extracts and pharmaceutical formulations. J. Pharm. Biomed. Anal. 26, 539-545. (Pubitemid 32763222)
16. Elzoghby, A.O., Helmy, M.W., Samy, W.M., Elgindy, N.A., 2013a. Spray-dried casein-based micelles as a vehicle for solubilization and controlled delivery of flutamide Formulation, characterization, and in vivo pharmacokinetics. Eur. J. Pharm. Biopharm., http://dx.doi.org/10.1016/j.ejpb. 2013.01.005.
17. Elzoghby, A.O., Samy, W.M., Elgindy, N.A., 2013b. Novel spray-dried genipin-crosslinked casein nanoparticles for prolonged release of alfuzosin hydrochloride. Pharm. Res. 30, 512-522.
18. Fakes, M.G., Vakkalagadda, B.J., Qian, F., Desikan, S., Gandhi, R.B., Lai, C., Hsieh, A., Franchini, M.K., Toale, H., Brown, J., 2009. Enhancement of oral bioavailability of an HIV-attachment inhibitor by nanosizing and amorphous formulation approaches. Int. J. Pharm. 370, 167-174.
19. Freag, M.S., Elnaggar, Y.S.R., Abdallah, O.Y., 2013. Lyophilized self-phytosomal nanocarriers (LSPNs) as platforms for enhanced diosmin delivery: optimization and ex-vivo permeation. Int. J. Nanomed. 8, 2385-2397.
20. Galli, C., 2006. Experimental determination of the diffusion boundary layer width of micron and submicron particles. Int. J. Pharm. 313, 114-122.
21. Gandia, P., Lacombe, O., Woodley, J., Houin, G., 2004. The perfused everted intestinal segment of rat. Arzneim. Forsch. (Drug Res.) 54, 467-473.
22. 14C-diosmin tablets after oral administration to healthy volunteers by accelerator mass spectrometry and liquid scintillation counting. J. Pharm. Sci. 91, 32-40.
23. Genty, M., Gonzalez, G., Clere, C., Desangle-Gouty, V., Legendre, J.Y., 2001. Determination of the passive absorption through the rat intestine using chromatographic indices and molar volume. Eur. J. Pharm. Sci. 12, 223-229.
24. Hitzenberger, G., 1997. Therapeutic effectiveness of flavonoids illustrated by daflon 500 mg. Wien. Med. Wochenschr. 147, 409-412. (Pubitemid 27501966)
25. Jacobs, C., Kayser, O., Müller, R.H., 2000. Nanosuspensions as a new approach for the formulation for the poorly soluble drug tarazepide. Int. J. Pharm. 196, 161-164. (Pubitemid 30105734)
26. Kamalpreet, S., Maheshwari, M., 2012. Development and evaluation of novel microemulsion based oral formulations of 5 fluorouracil using non-everted rat intestine sac model. Drug Dev. Ind. Pharm. 38, 294-300.
27. Kaul, S., Ritschel, W.A., 1981. Studies of the intestinal transfer of coumarin and 7-hydroxycoumarin across guinea pig and rat small intestine. Arzneim. Forsch. (Drug Res.) 31, 790-795. (Pubitemid 11114380)
28. Kayser, O., 2001. A new approach for targeting to Cryptosporidium parvum using mucoadhesive nanosuspensions: research and applications. Int. J. Pharm. 214, 83-85. (Pubitemid 32244083)
29. Kesisoglou, F., Panmai, S., Wu, Y., 2007. Nanosizing-oral formulation development a biopharmaceutical evaluation. Adv. Drug. Deliv. Rev. 59, 631-644. (Pubitemid 47285408)
30. Lai, F., Sinico, C., Ennas, G., Marongiu, F., Marongiu, G., Fadda, A.M., 2009. Diclofena nanosuspensions: influence of preparation procedure and crystal form on drug dissolution behaviour. Int. J. Pharm. 373, 124-132.
31. Lee, J., 2008. Characteristics of polymers enabling nanocomminution of water-insoluble drugs. Int. J. Pharm. 355, 328-336.
32. Le Ferrec, E., Chesne, C., Artusson, P., Brayden, D., Fabre, G., Gires, P., 2001. In vitro models of the intestinal barrier. ATLA Altern. Lab Anim. 29, 649-668.
33. Lennernas, H., Nylander, S., Ungell, A., 1997. Jejunum permeability: a comparison between the using chamber technique and the single-pass perfusion in humans. Pharm. Res. 14, 667-671. (Pubitemid 27220288)
34. Mou, D., Chen, H., Wan, J., Xu, H., Yang, X., 2011. Potent dried drug nanosuspensions for oral bioavailability enhancement of poorly soluble drugs with pH-dependent solubility. Int. J. Pharm. 413, 237-244.
35. Muller, R.H., Peters, K., 1998. Nanosuspensions for the formulation of poorly soluble drugs preparation by a size-reduction technique. Int. J. Pharm. 160, 229-237. (Pubitemid 28083096)
36. Muller, R.H., Jacobs, C., Kayser, O., 2001. Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. Adv. Drug. Deliv. Rev. 47, 3-19. (Pubitemid 32209229)
37. Pohlmann, A.R., Weiss, V., Mertins, O., da Silveira, N.P., Guterres, S.S., 2002. Spray-dried indomethacin-loaded polyester nanocapsules and nanospheres: development, stability evaluation and nanostructure models. Eur. J. Pharm. Sci. 16, 305-312.
38. Patil, L.D., 2009. Development of validation of analytical methodology for determination of content and dissolution evaluation, Thesis: http://www.radarciencia.org; (accessed February 2013).
39. Rabinow, B.E., 2004. Nanosuspensions in drug delivery. Nat. Rev. Drug Discov. 3, 785-796. (Pubitemid 39242830)
40. Rasenack, N., Hartenhauer, H., Müller, B.W., 2003. Microcrystals for dissolution rate enhancement of poorly water-soluble drugs. Int. J. Pharm. 254, 137-145. (Pubitemid 36298822)
41. Ruan, L.-P., Chen, S., Yu, B.-Y., Zhu, D.-N., Cordell, G.A., Qiu, S.X., 2006. Prediction of human absorption of natural compounds by the non-everted rat intestinal sac model. Eur. J. Med. Chem. 41, 605-610. (Pubitemid 43766796)
42. Ruell, J.A., Tsinman, O., Avdeef, A., 2004. Acid-base cosolvent method for determining aqueous permeability of amiodarone, itraconazole, tamoxifen, terfenadine and other very insoluble molecules. Chem. Pharm. Bull. 52, 561-565. (Pubitemid 41701905)
43. Sharma, P., Chawla, H.P.S., Panchagnula, R., 2002. LC determination of cephalosporins in vitro in rat intestinal sac absorption model. J. Pharm. Biomed. Anal. 27, 39-50. (Pubitemid 33001380)
44. Sharma, P., Garg, S., 2010. Pure drug and polymer based nanotechnologies for the improved solubility, stability, bioavailability and targeting of anti-HIV drugs. Adv. Drug Deliv. Rev. 62, 491-502.
45. Shegokar, R., Müller, R.H., 2010. Nanocrystals: industrially feasible multifunctional formulation technology for poorly soluble actives. Int. J. Pharm. 399, 129-139.
46. Sosnik, Á.M., Carcaboso Glisoni, R.J., Moretton, M.A., Chiappetta, D.A., 2010. New old challenges in tuberculosis: potentially effective nanotechnologies in drug delivery. Adv. Drug Deliv. Rev. 62, 547-559.
47. Tanaka, T., Makita, H., Kawabata, K., Mori, H., Kakumoto, M., Satoh, K., Hara, A., Sumida, T., Ogawa, H., 1997. Chemoprevention of azoxymethane-induced rat colon carcinogenesis by the naturally occurring flavonoids, diosmin and hesperidin. Carcinogenesis 18, 957-965. (Pubitemid 28132340)
48. Tewa-Tagne, P., Degobert, G., Briançon, S., Bordes, C., Gauvrit, J-Y., Lanteri, P., Fessi, H., 2007. Spray-drying nanocapsules in presence of colloidal silica as drying auxiliary agent: formulation and process variables optimization using experimental designs. Pharm. Res. 24, 650-661. (Pubitemid 46411954)
49. Thassu, D., Deleers, M., Pathak, Y., 2007. Nanoparticulate Drug Delivery Systems. Informa Healthcare USA, Inc.
50. Van, D.M.G., Van, E.B., Froyen, L., Van, H.J., Martens, J.A., Augustijns, P., 2008. Drying of crystalline drug nanosuspensions-the importance of surface hydrophobicity on dissolution behavior upon redispersion. Eur. J. Pharm. Sci. 35, 127-135.
51. Verma, S., Huey, B.D., Burgess, D.J., 2009. A scanning probe microscopy method form nanosuspension stabilizer selection. Langmuir 25, 12481-12487.
52. Verma, S., Kumara, S., Gokhale, R., Burgess, D.J., 2011. Physical stability of nanosuspensions: investigation of the role of stabilizers on Ostwald ripening. Int. J. Pharm. 406, 145-152.
53. Yang, M., Tanaka, T., Hirose, Y., Deguchi, T., Mori, H., Kawada, Y., 1997. Chemopreventive effects of diosmin and hesperidin on N-butyl-N-(4- hydroxybutyl)nitrosamine-induced urinary-bladder carcinogenesis in male ICR mice. Int. J. Cancer 73, 719-724. (Pubitemid 127483070)
54. Zhang, H., Hollis, C.P., Zhang, Q., Tonglei, L., 2011a. Preparation and antitumor study of camptothecin nanocrystals. Int. J. Pharm. 415, 293-300.
55. Zhang, T., Murowchick, J., Youan, B.C., 2011b. Optimization of formulation variables affecting spray-dried oily core nanocapsules by response surface methodology. J. Pharm. Sci. 100, 1031-1044.